Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Ovarian Neoplasms 44Lung Neoplasms 29Neuroblastoma 24Small Cell Lung Carcinoma 21Carcinoma, Ovarian Epithelial 19Fallopian Tube Neoplasms 17Neoplasms 14Brain Neoplasms 14Uterine Cervical Neoplasms 11Leukemia, Myeloid, Acute 11Leukemia 11Retinoblastoma 10Glioma 9Recurrence 8Sarcoma 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Lymphoma 7Central Nervous System Neoplasms 7Sarcoma, Ewing 6Neoplasm Metastasis 6Lymphoma, Follicular 6Unspecified Adult Solid Tumor, Protocol Specific 5Osteosarcoma 5Gliosarcoma 5Glioblastoma 5Endometrial Neoplasms 5Burkitt Lymphoma 5Blast Crisis 5Astrocytoma 5Wilms Tumor 4

Interventions

Cyclophosphamide 27fludarabine phosphate 21Cyclosporine 19Mycophenolic Acid 16Busulfan 16Cord Blood Stem Cell Transplantation 15Antilymphocyte Serum 14Whole-Body Irradiation 13Radiotherapy 13Peripheral Blood Stem Cell Transplantation 11Methylprednisolone 9Filgrastim 7Methotrexate 6Melphalan 6Tacrolimus 5fludarabine 4Thiotepa 4Etoposide 4Cytarabine 4sargramostim 3Granulocyte Colony-Stimulating Factor 3Cyclosporins 3Azacitidine 3Decitabine 2Arsenic Trioxide 24-phenylbutyric acid 2vatalanib 1poly ICLC 1paricalcitol 1lintuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Anemia, Refractory × Topotecan × Clear all
NCT00003675 2016-07-20

Topotecan in Treating Patients With Myelodysplastic Syndrome

Alliance for Clinical Trials in Oncology

Phase 2 Completed
100 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Leukemia, Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡